JP2005500053A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500053A5 JP2005500053A5 JP2003519412A JP2003519412A JP2005500053A5 JP 2005500053 A5 JP2005500053 A5 JP 2005500053A5 JP 2003519412 A JP2003519412 A JP 2003519412A JP 2003519412 A JP2003519412 A JP 2003519412A JP 2005500053 A5 JP2005500053 A5 JP 2005500053A5
- Authority
- JP
- Japan
- Prior art keywords
- gpr86
- adp
- substance
- polypeptide
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101001120082 Homo sapiens P2Y purinoceptor 13 Proteins 0.000 claims description 59
- 102100026168 P2Y purinoceptor 13 Human genes 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 26
- 230000000694 effects Effects 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 108091033319 polynucleotide Proteins 0.000 claims description 5
- 102000040430 polynucleotide Human genes 0.000 claims description 5
- 239000002157 polynucleotide Substances 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 4
- 238000002405 diagnostic procedure Methods 0.000 claims description 3
- 239000000556 agonist Substances 0.000 claims description 2
- 239000005557 antagonist Substances 0.000 claims description 2
- 101000621371 Homo sapiens WD and tetratricopeptide repeats protein 1 Proteins 0.000 claims 24
- 101000892274 Human adenovirus C serotype 2 Adenovirus death protein Proteins 0.000 claims 24
- 101000820656 Rattus norvegicus Seminal vesicle secretory protein 4 Proteins 0.000 claims 24
- 102100023038 WD and tetratricopeptide repeats protein 1 Human genes 0.000 claims 24
- 210000004027 cell Anatomy 0.000 claims 22
- 102000004196 processed proteins & peptides Human genes 0.000 claims 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 229920001184 polypeptide Polymers 0.000 claims 20
- 239000000126 substance Substances 0.000 claims 20
- 230000007781 signaling event Effects 0.000 claims 16
- 239000000523 sample Substances 0.000 claims 12
- 238000001514 detection method Methods 0.000 claims 7
- 230000011664 signaling Effects 0.000 claims 6
- 230000008482 dysregulation Effects 0.000 claims 5
- 239000011230 binding agent Substances 0.000 claims 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 3
- 210000000170 cell membrane Anatomy 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 3
- 230000007423 decrease Effects 0.000 claims 3
- 239000002853 nucleic acid probe Substances 0.000 claims 3
- 239000005022 packaging material Substances 0.000 claims 3
- 206010003571 Astrocytoma Diseases 0.000 claims 2
- 101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- 230000034303 cell budding Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- DYNGCIHMNWOBSU-MSQVLRTGSA-K trisodium;[[(2r,3s,4r,5r)-5-(6-amino-2-methylsulfanylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].C12=NC(SC)=NC(N)=C2N=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O DYNGCIHMNWOBSU-MSQVLRTGSA-K 0.000 claims 2
- 108010000239 Aequorin Proteins 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 102000003923 Protein Kinase C Human genes 0.000 claims 1
- 108090000315 Protein Kinase C Proteins 0.000 claims 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 1
- 108700008625 Reporter Genes Proteins 0.000 claims 1
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 claims 1
- 102000030621 adenylate cyclase Human genes 0.000 claims 1
- 108060000200 adenylate cyclase Proteins 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 150000001982 diacylglycerols Chemical class 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 238000002875 fluorescence polarization Methods 0.000 claims 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000014509 gene expression Effects 0.000 claims 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 150000003905 phosphatidylinositols Chemical class 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 238000010791 quenching Methods 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940125425 inverse agonist Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/924,125 US6946244B2 (en) | 2001-08-07 | 2001-08-07 | Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13) |
| PCT/EP2002/008761 WO2003014731A2 (en) | 2001-08-07 | 2002-08-06 | The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005500053A JP2005500053A (ja) | 2005-01-06 |
| JP2005500053A5 true JP2005500053A5 (enExample) | 2006-01-12 |
| JP4372545B2 JP4372545B2 (ja) | 2009-11-25 |
Family
ID=25449739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003519412A Expired - Lifetime JP4372545B2 (ja) | 2001-08-07 | 2002-08-06 | オーファンｇタンパク質共役型レセプターｇｐｒ８６の天然リガンドと使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6946244B2 (enExample) |
| EP (1) | EP1421377B1 (enExample) |
| JP (1) | JP4372545B2 (enExample) |
| AT (1) | ATE324585T1 (enExample) |
| CA (1) | CA2453486C (enExample) |
| DE (1) | DE60210989T2 (enExample) |
| DK (1) | DK1421377T3 (enExample) |
| ES (1) | ES2262819T3 (enExample) |
| WO (1) | WO2003014731A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004015422A2 (en) * | 2002-08-05 | 2004-02-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) |
| GB2394286A (en) * | 2002-09-17 | 2004-04-21 | Innovab Ltd | An assay for adp using an adp binding protein |
| WO2004082571A2 (en) * | 2003-03-18 | 2004-09-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) |
| GB0312845D0 (en) * | 2003-06-04 | 2003-07-09 | Paradigm Therapeutics Ltd | Use of componds in medicine |
| GB0312844D0 (en) * | 2003-06-04 | 2003-07-09 | Paradigm Therapeutics Ltd | Use of compounds in medicine |
| JP4926952B2 (ja) * | 2004-07-01 | 2012-05-09 | 武田薬品工業株式会社 | Ｇｐｒ８６受容体の使用 |
| AU2005258934A1 (en) | 2004-07-01 | 2006-01-12 | Paradigm Therapeutics Limited | Use of the receptor GPR86 |
| ES2322727B1 (es) * | 2005-07-28 | 2010-04-22 | Universidad Del Pais Vasco | Metodo para cuantificar la union receptor acoplado a proteina g (gpcr)-proteina g mediante el empleo de un array de membranas celulares. |
| EP1959968A2 (en) | 2005-12-06 | 2008-08-27 | P2-Science APS | Modulation of the p2y2 receptor pathway |
| GB0817166D0 (en) | 2008-09-19 | 2008-10-29 | Medical Res Council | Sensor |
| EP3744348B1 (en) | 2016-05-06 | 2022-03-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (aml) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6162899A (en) * | 1997-10-23 | 2000-12-19 | Smithkline Beecham Corporation | Human HNEAA81 receptor |
| CA2239255A1 (en) * | 1997-10-23 | 1999-04-23 | Smithkline Beecham Corporation | Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
| CA2645717A1 (en) * | 1998-11-20 | 2000-06-02 | Arena Pharmaceuticals, Inc. | Human orphan g protein-coupled receptors |
| US6689866B1 (en) * | 1999-03-09 | 2004-02-10 | Curagen Corporation | Polynucleotides and proteins encoded thereby |
| US6863889B2 (en) * | 1999-03-09 | 2005-03-08 | Curagen Corporation | Polynucleotides and proteins encoded thereby |
| WO2002061087A2 (en) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
| US20030059878A1 (en) * | 2001-07-06 | 2003-03-27 | Tanabe Seiyaku Co., Ltd | Novel purinoceptor and gene thereof |
-
2001
- 2001-08-07 US US09/924,125 patent/US6946244B2/en not_active Expired - Lifetime
-
2002
- 2002-08-06 CA CA2453486A patent/CA2453486C/en not_active Expired - Lifetime
- 2002-08-06 DK DK02748870T patent/DK1421377T3/da active
- 2002-08-06 ES ES02748870T patent/ES2262819T3/es not_active Expired - Lifetime
- 2002-08-06 JP JP2003519412A patent/JP4372545B2/ja not_active Expired - Lifetime
- 2002-08-06 EP EP02748870A patent/EP1421377B1/en not_active Expired - Lifetime
- 2002-08-06 DE DE60210989T patent/DE60210989T2/de not_active Expired - Lifetime
- 2002-08-06 AT AT02748870T patent/ATE324585T1/de active
- 2002-08-06 WO PCT/EP2002/008761 patent/WO2003014731A2/en not_active Ceased
- 2002-12-03 US US10/308,968 patent/US20040005629A1/en not_active Abandoned
-
2005
- 2005-08-31 US US11/216,987 patent/US7422846B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sosinsky et al. | Structural organization of gap junction channels | |
| US11435365B2 (en) | Markers for renal disease | |
| JP5604782B2 (ja) | 受容体再構築物、ならびにこれを用いる疾病検査法 | |
| McCulloch et al. | Multiple roles for the C-terminal tail of the chemokine scavenger D6 | |
| US20090226949A1 (en) | Single-cell biosensor for the measurement of GPCR ligands in a test sample | |
| JP2005500053A5 (enExample) | ||
| US9316652B2 (en) | Method for diagnosing Lyme disease using a cellular immunological test | |
| WO2008007373B1 (en) | Method and assay for glycosylation pattern detection related to cell state | |
| JP2005047895A (ja) | Ｈｃｖ調節タンパク質 | |
| CA2843631A1 (en) | Methods and kits for diagnosing and/or prognosing osteoarthritis | |
| US8338566B2 (en) | Characterization of BBK07 antigen of Borrelia burgdorferi and methods of use | |
| Cho et al. | Comparative evaluation of sensitivity to hexanal between human and canine olfactory receptors | |
| US7399830B2 (en) | Synaptic activation protein compositions and method | |
| Trier | Characterization of peptide antibodies by epitope mapping using resin-bound and soluble peptides | |
| US20120296067A1 (en) | Compound capable of binding to naturally occurring denatured protein, and method for screening for the compound | |
| US20250264456A1 (en) | System and method for biomolecule detection | |
| WO2004084800A2 (en) | A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use | |
| WO2005121356A1 (ja) | 新規スクリーニング方法 | |
| Schulz et al. | Microarray profiling of skeletal muscle sarcoplasmic reticulum proteins | |
| JP2004279334A (ja) | 変形性関節症の検定方法 | |
| US20060134710A1 (en) | WDR11 protein assay | |
| JP2010075064A (ja) | 微量化学物質を検出するための核酸および方法 | |
| Lam | The characterization of a novel family C G-protein coupled receptor musGPRC6A | |
| JP2012115195A (ja) | バセドウ病の検査方法、バセドウ病の予防薬または治療薬のスクリーニング方法、およびバセドウ病検査用のキット | |
| Hakobyan et al. | Novel monoclonal antibodies specific for the Y402 and H402 variants of complement factor H: Tools for risk prediction in AMD and for separation of alleles in other pathologies |